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Abstract 
In previous work, we demonstrated that two probiotic strains, namely Lactobacillus casei PRA205 
and Lactobacillus rhamnosus PRA331, produce fermented milks with potent angiotensin-
converting enzyme (ACE)-inhibitory and antioxidant activities. Here, we tested these strains for the 
survivability and the release of antihypertensive and antioxidant peptides in yogurt fermentation and 
cold storage. For these purposes three yogurt batches were compared: one prepared using yogurt 
starters alone (Lactobacillus delbrueckii subspecies bulgaricus 1932 and Streptococcus 
thermophilus 99), and the remaining two containing either PRA205 or PRA331 in addition to 
yogurt starters. Despite the lower viable counts at the fermentation end compared to PRA331, 
PRA205 overcame PRA331 in survivability during refrigerated storage for 28 days, leading to 
viable counts (>108 CFU/g) higher than the minimum therapeutic threshold (106 CFU/g). Analyses 
of in vitro ACE-inhibitory and antioxidant activities of peptide fractions revealed that yogurt 
supplemented with PRA205 displays higher amounts of antihypertensive and antioxidant peptides 
than that produced with PRA331 at the end of fermentation and over storage. Two ACE-inhibitory 
peptides, Valine-Proline-Proline (VPP) and Isoleucine-Proline-Proline (IPP), were identified and 
quantified. This study demonstrated that L. casei PRA205 could be used as adjunct culture for 
producing bi-functional yogurt enriched in bioactive peptides and in viable cells, which bring health 
benefits to the host as probiotics.  
Keywords: Lactobacillus; antioxidant peptides; antihypertensive peptides; probiotics; yogurt. 
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1. Introduction 
Probiotics are live micro-organisms that, when administered in adequate amounts, confer 
health benefits on the host (FAO 2006). Depending upon the strain and/or the species, probiotics 
survive transit through the gastro-intestinal tract (GIT) and provide measurable health benefits 
owing to their ability to modulate immune system of the host, balance intestinal microflora, and 
produce functionally valuable products (Kanmani et al., 2013). Recently, the traditional 
recommendation that probiotic strains for humans should come from humans (species-specificity 
criterion) (Vasiljevic and Shah, 2008) is becoming mitigated, because several starter and non-starter 
lactic acid bacteria (SLAB and NSLAB) isolated from fermented dairy products have been proven 
to possess healthy properties, beyond their technological functions (Milesi et al., 2009; Settanni and 
Moschetti, 2010). In particular, NSLAB belong to species from which probiotic strains were 
isolated and characterized (Lactobacillus casei, Lactobacillus paracasei, and Lactobacillus 
rhamnosus) and, taken advantage from their proteolytic systems, they can release bioactive peptides 
primarily from αS1- and β-caseins, with proven anti-oxidant and anti-hypertensive activities 
(Pihlanto and Korhonen, 2014 and references therein). 
In recent years, probiotics have increasingly entered the food supply as dietary adjuncts in 
variety of food system (Smug et al., 2014). One of the most popular fermented milk products for the 
delivery of probiotics cultures is yogurt (Lourens-Hattingh and Viljoen, 2001). According to the 
Codex standard for fermented milks (CODEX 2003), yogurt is strictly defined as milk fermented 
with symbiotic starter cultures of Streptococcus thermophilus and Lactobacillus delbrueckii 
subspecies bulgaricus, which shall be in a viable state, active and still present in the product 
through the end of shelf life (FAO/WHO, 2011). Yogurt starter cultures may be considered 
probiotic since they may help to lessen the symptoms of lactose intolerance thanks to the release of 
lactose-hydrolyzing enzymes (Adolfsson et al., 2004; Guarner et al., 2005). However, yogurt starter 
cultures are not bile-resistant or acid-tolerant and thus cannot survive under the GIT conditions 
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(Vinderola and Reinheimer, 2003; del Campo et al., 2005). The terms ‘yogurt-like product’ or ‘bio-
yogurt’ or ‘functional yogurt’ are used to define alternative culture yogurt (i.e. when L. bulgaricus 
is substituted by other Lactobacillus species for the fermentation of milk) or yogurt containing 
probiotic bacteria (Guarner et al., 2005). Saxelin et al. (2010) demonstrated that yogurts and 
fermented milks were as effective as capsules for the administration of probiotic bacteria, 
emphasizing the importance of such matrices as functional food matrices. 
Obtaining desirable therapeutic effects in probiotic yogurts requires the viability of the 
starter and probiotic cultures to be maintained at a sufficient level throughout storage of the product. 
It has been suggested that probiotics should be present in the food product in minimal amounts of 
106 colony forming units (CFU)/g. This amount could be translated into ≥ 106 CFU/g/day of 
probiotics-containing yogurt given that 100 g is the daily serving portion. Such high dosage is 
required to compensate for the loss of cells during the passage through the upper and lower parts of 
the GIT (Tamime et al., 2005; Granato et al., 2010). 
From a technological standpoint, yogurt supplementation with probiotic cultures is not easy, 
particularly with respect to maintaining the viability of the cultures (Corcoran et al., 2008). Many 
factors influence the viability of probiotics in yogurts: strain variation, acid accumulation, 
interaction with starter cultures, levels of dissolved oxygen and hydrogen peroxide (H2O2), and 
storage condition (Nighswonger et al., 1996; Donkor et al., 2006). Several studies reported that 
some commercially available dairy products contain insufficient number of viable probiotics (as 
defined by < 106 CFU/g or mL before the expiration date), thereby diminishing the potential health 
benefits conferred by these products (Coeuret et al., 2004, Huys et al., 2006, Lin et al., 2006). 
In our previous works, we demonstrated that two NSLAB probiotic strains isolated from 
Parmigiano Reggiano cheese, namely L. casei PRA205 and L. rhamnosus PRA331, were able to 
resist GIT conditions (Solieri et al., 2014) and to release hypotensive casokinins Valine-Proline-
Proline (VPP) and Isoleucine-Proline-Proline (IPP) during milk fermentation (Solieri et al., 2015). 
VPP and IPP resist GIT transit and cross the mucosal barrier, without being digested by serum 
5 
 
peptidases (Foltz et al., 2008). They in vivo reduce systolic blood pressure both in animal and 
human models  owing to multiple anti-hypertensive actions, such as inhibition of angiotensin-
converting enzyme (ACE), stimulation of vasodilator production, and modulation of sympathetic 
nervous activity (Boelsma and Kloek, 2010, Nakamura et al., 2011; Cicero et al., 2013). 
The aim of the present work was to develop bi-functional yogurts, which deliver viable cells 
of potential probiotics L. casei PRA205 and L. rhamnosus PRA331 and their bioactive peptides 
VPP and IPP. Three set-type yogurts were prepared in order to evaluate the viability of probiotics 
during yogurt fermentation and 28 day (d) long refrigeration, as well as to investigate their effect on 
proteolytic, anti-hypertensive and antioxidant activities of TCA soluble peptide extracts from 
yogurts. 
2. Materials and methods 
2.1 Strains, media and culture conditions 
Streptococcus thermophilus 99 and L. delbrueckii ssp. bulgaricus 1932 (L. bulgaricus) were 
kindly provided by Prof. Camilla Lazzi (University of Parma, Italy) and cultured for 24 h at 42°C 
under anaerobic conditions (AnaeroGen, Oxoid, Basingstoke, UK) in M17 (Oxoid Basingstoke, 
UK) supplemented with 2% (w/v) lactose (LM17), and MRS (Oxoid Basingstoke, UK) media, 
respectively. Lactobacillus rhamnosus PRA331 and Lactobacillus casei PRA205 (deposited in the 
Unimore Culture Collection; www.umcc.unimore.it) were isolated from ripened Parmigiano 
Reggiano cheeses (Solieri et al., 2012) and routinely cultured in MRS medium for 24 h at 37°C. 
Prior to the experimental use, each culture was twice propagated in the corresponding growth 
medium. All LAB strains were maintained as frozen stock at -80°C in MRS or LM17 broth 
supplemented with glycerol at the final concentration of 25% (w/v). 
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2.2 Correlation curve between optical density and cell counts 
To standardize the inoculum, exponentially growing cells of each bacterial strain with 
approximately 108-109 cells/mL were serially diluted (1, −2, −4, −8, −10 fold) with saline solution 
in duplicate. Then OD600 of the samples was measured spectrophotometrically. Sterile saline 
solution was used as blank. For counting cell numbers, the serially diluted bacterial cultures were 
further diluted with saline solution. Then the CFU measurements were typically obtained by 
spreading 100 μL of culture on 9-cm plates to obtain 100–400 colonies on the appropriate growth 
medium as reported above. The correlation between OD660 and cell count (CFU/mL) was 
established for each bacterial species by means of a standard curve. Correlation curves of OD600 vs. 
CFU/mL and conversion factors were listed in Table S1. 
2.3 Determination of proteolytic activity in milk 
The proteolytic activity of single cultures of starter and probiotic strains was determined in 
UHT cow skimmed milk over a fermentation time of 72 h, as previously described (Solieri et al., 
2015). 
2.4 Yogurt preparation and storage 
Yogurt preparation and experimental strategy are summarized in Fig. 1. Briefly, yogurt was 
prepared by heat-treating reconstituted skimmed milk (14 % w/v) at 85°C for 30 min followed by 
cooling to 45°C, and aseptically inoculating with 107 CFU/mL of each of L. bulgaricus and S. 
thermophilus. The inoculated milk was divided into equal portions; one portion was used as a 
control (referred to as yogurt 1), while the other portions were further inoculated with 107 CFU/mL 
of probiotic culture either of L. casei (referred to as yogurt 2) or L. rhamnosus (referred to as yogurt 
3), separately. Non-inoculated milk was used as negative control. The mixes were poured into 
polystyrene cups aseptically and incubated at 42°C. Decrease of pH was monitored every 1.5-3 h 
until the required pH value of 4.5 ± 0.5 was reached (approx. 8 h). Cooling to 4°C was done to halt 
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further acidification. Yogurts were stored at 4°C for 28 days (d), the typical shelf life of commercial 
yogurts. Aliquots of samples were removed after 8 h of fermentation at 42°C and at 3, 14 e 28 d of 
cold storage for subsequent microbiological and biochemical characterizations. Aliquots of yogurt 
were treated with 1% TCA for 10 min and centrifuged (10,000 x g, 20 min, 4°C) to obtain TCA-
soluble supernatants containing peptide fractions. The experiments were carried out in triplicate. 
2.5 Selective enumeration of LAB species 
Cell populations of yogurt starters S. thermophilus and L. bulgaricus were selectively 
enumerated using LM17 medium under aerobic incubation at 45°C for 24 h and MRS agar medium 
(pH adjusted to 5.2 using 1 mol/L HCl) at 45°C for 72 h anaerobically, respectively. Probiotic 
cultures of L. casei and L. rhamnosus were selectively enumerated from yogurt cultures using MRS 
vancomycin agar (pH 6.2; 1 ppm vancomycin) at 37°C for 72 h anaerobically (Sah et al., 2014). 
Plates containing 25–250 colonies were considered for enumeration and the results were reported as 
log CFU/g.  
2.6 Determination of proteolytic and antioxidant activities from yogurts 
Proteolytic activity was quantified by measuring the amount of released amino groups in 
TCA-soluble supernatants using TNBS method (Adler-Nissen, 1979). A calibration curve was 
prepared using leucine as standard (range 0.1-2.0 mmol/L). The results were expressed as mmol/L 
of leucine equivalents. The radical scavenging activity of TCA-soluble supernatants was measured 
using the ABTS method (Re et al., 1999) and the results were expressed as µmol/L of Trolox. 
2.7 Angiotensin I-converting enzyme (ACE) inhibitory activity 
ACE inhibitory (ACEi) activity of TCA-soluble supernatants was determined 
spectrophotometrically as reported by Ronca-Testoni (1983) using the tripeptide, 2-furanacryloyl–
phenylalanylglycylglycine (FAPGG) as substrate, with some modifications. Briefly, 600 µL of 
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FAPGG solution (1.33 mmol/L in reaction buffer containing 100 mmol/L TrisHCl, 0.6 mol/L NaCl, 
pH 8.2), were mixed directly in cuvette with 100 µL of the same reaction buffer or 100 µL of 
samples. The solution was kept at 37°C for 3 min before adding 21 µL of ACE solution in order to 
reach the final enzyme activity of 50 mU/mL. The reaction was monitored at 345 nm for 10 min. 
The ACE inhibitory activity was calculated as percent of inhibition (ACEi%). 
2.8 Determination of VPP and IPP 
The identification and quantification of IPP and VPP were carried out on 2 µL of suitably 
diluted TCA-soluble supernatant through nanoLC-MS/MS experiments performed on a 1200 Series 
Liquid Chromatographic two-dimensional system coupled to a 6520 Accurate-Mass Q-TOF LC/MS 
(Agilent Technologies, Milano, Italy). Chromatographic separation was performed on a ProtID-
Chip- 43(II) including a 4 mm 40 nL enrichment column and a 43 mm x 75 mm analytical column, 
both packed with a C18 phase (Agilent Technologies). The mobile phase composition and the 
gradient were the same as reported by Solieri et al. (2015). The mass spectrometer was tuned, 
calibrated and set with the same parameters as reported by Dei Più et al. (2014). VPP and IPP were 
selectively fragmented using a mass to charge ratio of 312.18 and 326.21 (charge +1), respectively 
and identified by comparing the retention time and fragmentation spectra of a synthetic standard 
tripeptide. VPP and IPP was quantified according to Solieri et al. (2015). The assignment process 
was complemented and validated by the manual inspection of MS/MS. 
2.9 Statistical analysis 
All experiments were carried out in triplicate and data are shown as means ± standard 
deviation (SD). We used two-way analysis of variance (ANOVA) followed by Tukey’s post hoc 
test to determine significant differences (P < 0.05) among means. Correlations between variables 
were assessed using Pearson's method. All analyses were performed with GraphPad Prism version 
6.00 (GraphPad software, San Diego, CA). 
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3. Results and Discussion 
In our previous work, we demonstrated that probiotic strains PRA205 and PRA331 release 
significant amounts of VPP and IPP from caseins starting from 48 h of milk fermentation (Solieri et 
al., 2015). Furthermore, L. casei PRA205 and L. rhamnosus PRA331 have been proven to possess 
good GIT-resistance and other functional properties, which make these strains promising probiotic 
candidates (Solieri et al., 2014). In this work, we investigated the possibility to develop yogurt 
carriers for delivering VPP and IPP-producers PRA205 and PRA331. However, probiotic bacteria 
grow slowly in milk and the rate of acidification is usually too slow to support an adequate 
fermentation process in yogurt (Tamime et al., 2005). Standard yogurt cultures, on the other hand, 
cause an accelerated and efficient lactic acid production during fermentation process of yogurt due 
to a proto-cooperation between L. bulgaricus and S. thermophilus. In order to develop yogurts with 
acceptable sensorial properties and to enrich yogurts in bioactive peptides and probiotic cells, we 
decided to test probiotic cultures as adjuncts in combination with starter yogurt cultures L. 
bulgaricus 1932 and S. thermophilus 99. 
3.1 Characterization of proteolytic activity of starter yogurt cultures and probiotic strains 
Conventionally, one of the proto-cooperative interactions between L. bulgaricus and S. 
thermophilus relies on the metabolite exchange of amino acids and peptides from the proteolytic L. 
bulgaricus to the non-proteolytic (Prt-) S. thermophilus (Sieuwerts et al., 2008). However, several 
S. thermophilus Prt+ strains have been recently documented in industrial bioprocesses, which were 
able to grow independently from L. bulgaricus in milk leading to substantial acidification (Delorme 
et al., 2010 and references therein). To evaluate whether S. thermophilus strain 99 has a Prt+ 
phenotype and to better understand how yogurt starter cultures affect proteolytic profiles of yogurt 
during co-fermentation with VPP and IPP-producer probiotic strains, we determined proteolytic 
activity of S. thermophilus 99 and L. bulgaricus 1932 during 72 h of milk fermentation. As shown 
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in Fig. S1, the milk fermented by S. thermophilus strain 99 exhibited higher concentrations of 
leucine equivalents than milk batches fermented by other strains during all the fermentation time. 
Therefore, S. thermophilus strain 99 displayed a strong Prt+ phenotype and overcame both L. 
bulgaricus starter strain 1932 and probiotic strains PRA205 and PRA331 in proteolytic activity. 
This Prt+ phenotype suggests that this S. thermophilus strain may possess the cell-envelope 
proteinase PrtS which initiates casein breakdown into oligopeptides (Delorme et al., 2010). 
3.2 Yogurt fermentation and viability of starter and probiotic cultures 
Yogurt acidification was monitored for each fermentation batch, as shown in Fig. S2. 
Supplementation of milk with only the starter cultures (yogurt 1) resulted in a substantially slower 
lowering of pH compared to co-fermentation trials with probiotic strains (P < 0.05). In particular, 
the milk acidification was enhanced when the yogurt starter strains 99 and 1932 were cultivated 
together with L. casei PRA205 compared to L. rhamnosus PRA331. This result disagrees with those 
obtained with mono-cultures, where milk acidification was higher with L. rhamnosus PRA331 than 
with L. casei PRA205 (Solieri et al., 2015). 
The first and most critical aspect in the development of a probiotic yogurt is the coexistence 
between starter and probiotic cultures, since a negative interaction can interplay between them. 
Factors such as dissolved oxygen, post-fermentation acidification and the consequent acid injuries 
may adversely influence the viability of probiotic strains (Vasiljevic and Shah, 2008). L. 
rhamnosus, L. acidophilus, and Bifidobacterium lactis appear to be inhibited when co-cultured with 
the fast-acidifying strain S. thermophilus, resulting in a low probiotic content of the final product 
(de Souza Oliveira et al., 2009). Vinderola et al. (2002) found that the cell-free supernatant obtained 
from skim milk cultures fermented by S. thermophilus and L. bulgaricus had no positive effect on 
probiotic L. casei, indicating that the extracellular products secreted by these yogurt bacteria were 
not conducive to the growth of L. casei. As the viability of probiotic organisms is considered a key 
parameter for developing probiotic yogurt, we determined the viable counts of probiotic and starter 
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organisms at the end of acidification and monitored their survival during a period of 28 d of 
refrigerated storage (Fig. 2). In yogurt 1 S. thermophilus and L. bulgaricus reached comparable 
viable counts at the end of acidification, without any strain dominating over the other (Fig. 2, panels 
A and B). In yogurts 2 and 3 starter culture concentrations were slightly affected by the presence of 
probiotic cultures after 8 h of acidification. In particular L. bulgaricus 1932 significantly increased 
viable cell counts from 8.52 ± 0.16 (yogurt 1) to 8.96 ± 0.19 log CFU/g (P < 0.05) in co-culturing 
with probiotic strain PRA205 (yogurt 2) (Fig. 2, panel B). At the end of fermentation, probiotic 
strain PRA331 exhibited higher viable counts (P < 0.05) than PRA205 (Fig. 2, panel C). 
During cold storage, species-specific bacterial counts differed between the yogurt 1 and the 
two probiotic yogurts 2 and 3, as well as between the two probiotic yogurts. There were minimal 
differences over time in the viability of S. thermophilus 99 during refrigeration of yogurt 1 (Fig. 2, 
panel A), whereas L. bulgaricus 1932 cell counts declined from 8.52 ± 0.16 to 6.50 log CFU/g (Fig. 
2, panel B). These results are congruent with previous findings, which indicated that S. 
thermophilus is more resistant to cold stress than L. bulgaricus (Donkor et al., 2007). Addition of L. 
casei PRA205 positively affected the S. thermophilus viable counts at the early cold storage (P < 
0.05) compared to control yogurt, but not those of L. bulgaricus which decreased of 100-fold. 
Compared to yogurt 1, the co-culturing of starter bacteria with L. rhamnosus determined an 
opposite trend, with the reduction of S. thermophilus survival at the early cold storage (P < 0.05), 
and the increase of L. bulgaricus viable counts. 
Although L. rhamnosus displayed higher viable counts at the beginning of refrigeration, cold 
storage resulted in a 100-fold decrease of its viable population (from 9.08 ± 0.09 to 7.29 ± 0.13 log 
CFU/g) (Fig. 2, panel C). In contrast, viable counts of L. casei PRA205 slightly increased during 
early storage (P < 0.05), which could be due to residual activity during this period; after that they 
remained relatively constant (approximately >108 CFU/g) over the late storage time (Fig. 2, panel 
C). Significantly, L. casei exhibited viable population at 4°C higher than S. thermophilus strain 99 
(P < 0.05). These results indicated that yogurt provided an environment that was favorable to 
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maintain high numbers of added L. casei cells during refrigerated storage. Remarkably, viable 
counts of probiotic strain PRA205 and, to a lesser extent, PRA331 after 28 d of refrigeration, were 
sufficient to exhibit probiotic effect, as the reported minimum therapeutic count of 106 CFU/g is 
below that obtained in the present work. 
3.3 Proteolytic activity 
Lactic acid bacteria produce proteolytic enzymes during yogurt manufacturing, which cleave 
peptide bonds of milk proteins leading to generation of bioactive peptides and free amino acids 
(Donkor et al., 2007). The extent of protein hydrolysis in yogurt samples was estimated by 
determining free amino groups, as reported in Fig. 3. Yogurt 2 displayed the highest amount of free 
amino groups at the end of fermentation. During refrigerated storage, the amount of free amino 
groups (expressed as mmol/L leucine equivalents) increased significantly (P < 0.05) in all samples, 
suggesting a continuation of proteolytic activities even at low temperature. In particular, the free 
amino group content remained significantly higher in yogurt 2 than yogurts 1 and 3 after 72 h of 
refrigeration, whereas a significant increase (P < 0.05) in proteolytic activity was observed in 
yogurt 1 compared to yogurt 2 and 3 starting from 14 d of cold storage. A similar reduction of free 
amino group content in co-culturing between starter and probiotic strains compared to starter yogurt 
control was also observed by Ramchandran et al. (2007), and it could be due to the higher demand 
for free amino acids and peptides required to sustain the survival of both starter and probiotic LABs 
compared to starter yogurt alone. 
When probiotic yogurts were compared each other, yogurt 2 (with L. casei PRA205) 
overcame (P < 0.05) yogurt 3 (with L. rhamnosus PRA331) in free amino group content at every 
time point of cold storage (Fig. 3). This result is congruent with the high proteolytic activities 
previously observed for L. casei strain PRA205 (Solieri et al., 2015) and with its higher stability in 
cold conditions compared to PRA331 (Fig. 2). Since S. thermophilus viable counts were similar in 
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yogurts 2 and 3, we supposed that the decline of L. bulgaricus viability observed in yogurt 2 at low 
temperature did not negatively affect the proteolytic potential of this probiotic yogurt. 
3.4 Antioxidant activity 
Protein hydrolysates can contain antioxidant peptides that can protect the human body by 
scavenging free radicals, such as reactive oxygen species, and also increase shelf life of foodstuffs 
by retarding the process of lipid peroxidation through hydrogen atom or electron transfer 
mechanisms (Pihlanto and Korhonen, 2014). To analyze the scavenging capacity of TCA-soluble 
extracts of yogurts, we used the ABTS assay and compared the antioxidant activities after yogurt 
manufacturing and during cold storage with that of the positive control, trolox, a vitamin E analog 
and known antioxidant. In order to confirm that the measured antioxidant activity was generated 
during the fermentation, the absorbance of TCA-soluble extract of skimmed milk immediately after 
inoculum was subtracted from that of the TCA-soluble extract from yogurts. The resulting values, 
expressed as μmol/L Trolox equivalents, are shown in Fig. 4. Generally, the antioxidant activities 
increased significantly (P < 0.05) during storage in all yogurt batches with respect to fermentation 
end. A positive correlation between proteolytic and ABTS scavenging activities was observed only 
for probiotic yogurts 2 (P < 0.05, Pearson r = 0. 93) and 3 (P < 0.05, Pearson r = 0.94). 
Furthermore, all yogurt samples exhibited varying degrees of scavenging capacities for ABTS 
radicals, indicating differences in generated TCA-soluble fractions of the yogurts. While yogurt 2 
exhibited antioxidant activity similar to yogurt 1 only at the end of fermentation, yogurt 1 overcame 
the probiotic yogurts in scavenging capacities for ABTS radicals during refrigeration, suggesting 
that the combination of starter and probiotic LABs lead to lower scavenger activity than starter 
cultures alone at low temperature (Fig. 4). However, yogurt co-fermented with PRA205 exhibited 
higher antioxidant values than yogurt co-fermented with PRA331, mainly at the end of refrigeration 
(Fig. 4). Previous works found that fermented milks and yogurts produced using mixed cultures 
showed a higher radical scavenging activity than milks fermented using a single strain (Virtanen et 
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al., 2006; Sah et al., 2014). In our case, we can speculate that competition between starter and 
probiotic cultures for free amino acids and peptides may reduce the antioxidant peptide fraction in 
yogurts 2 and 3. Moreover, the bioactivities of protein hydrolysates depend upon a number of 
factors, such as amino acid sequence, size and structure of the peptides, as well as on the types of 
enzyme from the LAB, as specific proteases are involved in the hydrolysis of specific peptide bonds 
(Sarmadi and Ismail, 2010).  
3.5 Angiotensin-converting enzyme inhibitory activity 
The search for ACEi activity is the most common method for the selection of antihypertensive 
peptides derived from milk proteins. Therefore, ACEi activity of TCA-soluble fractions was 
determined for all yogurt batches at end of fermentation and during storage at 4 °C (Fig. 5).  
Differently from those reported by previous authors (Donkor et al., 2005; Sah et al., 2014), 
the degree of ACE inhibition by yogurt produced supplemented with probiotic organisms was not 
always greater than that of the control yogurt consisting solely of the yogurt cultures. As expected 
from the increase of proteolytic activities starting from the middle stage of refrigeration, control 
yogurt overcame probiotic yogurts in ACEi percentage during cold storage, but not at the end of 
fermentation (Fig. 5). A similar difference between starter and probiotic batches was reported by 
Donkor et al. (2005) which found that ACEi activity increased from 70% to 90% in control yogurt 
and decreased from 100% to 70% in probiotic yogurt over 28 day refrigerated storage. Statistical 
analysis revealed a slight positive and statistically not significant correlation (Pearson r = 0.73; P > 
0.05) between the TNBS results and ACE inhibition, indicating that the extent of ACE inhibition 
might only partially depends on the extent of the proteolytic activity. In particular, despite enhance 
of proteolytic activity during cold storage (Fig. 3), in yogurt 1 ACEi activity declined (P < 0.05) 
from 14 to 28 d of refrigeration (Fig. 5). 
Overall, addition of L. casei PRA205 in yogurt formulation led to enrichment in ACEi 
peptides higher than L. rhamnosus PRA331. According to previous work (Solieri et al., 2015), 
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strain PRA205 exhibited a basal ACEi activity immediately after inoculum, which significantly 
increased after 8 h of fermentation at 42°C. Remarkably, this ACEi activity did not significantly 
change during cold storage (P > 0.05). This result indicated that, despite the declining number of 
live L. bulgaricus bacteria during refrigeration (Fig. 3), the proteinase-dependent activities of viable 
St. thermophilus and L. casei PRA205 cells were enough to counterbalance the breakdown of 
peptides into free amino acids by proteolytic peptidases released from lysing cells of L. bulgaricus. 
Remarkably, yogurt 1, which displayed higher proteolytic activity than yogurt 2 in the late stage of 
storage (Fig. 3), showed ACEi percentages similar (P > 0.05) to yogurt 2 after 28 d of refrigeration 
(Fig. 6). Similarly, Donkor et al. (2007) and Papadimitriou et al. (2007) found no significant 
differences in ACEi activity between yogurt containing starter cultures and yogurt containing both 
starter and probiotic L. paracasei cultures. Rojas-Ronquillo et al. (2012) observed that L. casei 
Shirota and S. thermophilus released ACEi peptides during milk fermentation. 
TCA-soluble peptides extracted from yogurt supplemented with PRA331 displayed a trend of 
ACE inhibition markedly different from that observed in probiotic strain PRA205 (Fig. 5). 
Differently from PRA205, strain PRA331 did not show any ACEi activity after inoculum. The 
maximum ACEi percentage was recorded after 72 h of refrigeration, thereafter the values drop out 
below the detection limits of the assay. These results are in agreement with previous observations 
that ACEi activity decreased when proteolysis exceeded a certain level (Pihlanto et al., 2010). The 
content of ACEi peptides appears to rely on a balance between their formation and further 
breakdown into inactive peptides and amino acids, in turn depending upon storage time and 
conditions (Lόpez-Fandiño et al., 2006). The decline in L. bulgaricus and L. rhamnosus viable 
counts at low temperature (Fig. 2, panels b and c) can contribute to the unbalance of 
formation/degradation rate of ACEi peptides towards their breakdown. The impact of 
aminopeptidase (PepN) and X-prolyl dipeptidyl aminopeptidase (PepX) activities of NSLAB has 
been poorly explored, but we speculate that some peptidases of L. rhamnosus may hydrolyze 
oligopeptides, decreasing the content of ACEi peptides. Accordingly, in L. helveticus and Lc. lactis 
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the depletion of peptidases PepX and PepN increases the ACEi activity during milk fermentation 
due to the hindering of peptide degradation (Algaron et al., 2004; Kilpi et al. 2007).  
3.6 Characterization of VPP and IPP contents 
During cold storage, yogurts 1 and 2 displayed higher ACEi activity than yogurt 3. 
Furthermore, probiotic PRA205 is a higher VPP and IPP- producer than PRA331 (Solieri et al., 
2015). In order to get further insights into the nature of bioactive peptides contributing to these 
observed ACEi activities, we determined VPP an IPP contents on crude peptide fractions extracted 
from yogurts 1, 2 and 3 after 3, 14 and 28 d of refrigeration. As shown in Fig.6 (panel A), in control 
yogurt 1 VPP amount was 334.3 ± 26.1 µg/L after 3 d of cold storage and increased (P < 0.05) 
during cold storage reaching a concentration of 1373.4 ± 463.0 µg/L at the end of refrigeration 
times. IPP concentration was much lower than VPP and followed the same trend of increase as VPP 
over storage (Fig. 6, panel B). A clear correlation was found between the amount of VPP and IPP 
and the proteolysis (Pearson r=0.7748; P=0.0142) whereas no correlation was observed between the 
amount of these lactrotripeptides and the ACEi values, suggesting that, in addition to VPP and IPP, 
other peptides with ACEi activity are released during yogurt manufacturing and cold storage. 
In yogurts supplemented with either L. casei PRA205 or L. rhamnosus PRA331 amounts of 
VPP and IPP were similar (P > 0.05) to that observed in starter yogurt after 3 d of cold storage (Fig. 
6, panels A and B). Similarly, Donkor et al. (2007) found VPP and IPP in yogurts prepared either 
using yogurt cultures L. bulgaricus and S. thermophilus, or L. acidophilus, L. casei and 
Bifidobacterium lactis in addition to yogurt culture. However, in our probiotic yogurt 2, VPP 
content increased from 3 to 28 d of refrigeration to a lesser extent (P < 0.05) respect to the yogurt 1, 
whereas IPP content did not change over storage (Fig. 6, panels A and B). Differently from yogurts 
1 and 2, the amount of VPP and IPP in yogurt 3 remained stable during the cold storage period. 
At the end of the cold storage, the sum of VPP and IPP in yogurt 1 (1684.3 ± 477.7 µg/L) was 
significantly (P < 0.05) higher than the sum of VPP and IPP found in yogurt 2 (734.4 ± 15.2 µg/L) 
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and 3 (505.0 ± 36.4 µg/L). However, yogurt 2, containing the strain PRA205, showed significantly 
higher amount (P < 0.05) of the lactotripeptides respect to the yogurt 3, containing PRA331, after 
28 d of cold storage.  
Results suggested that, despite all three yogurts containing VPP and IPP lactotripeptides, their 
amount resulted from a complex and dynamic interplay between formation and breakdown, which 
strongly depends on proteinase and/or peptidase specificity in the various microorganisms. In 
yogurts containing multiple probiotic and starter cultures, both the major requirements for amino 
acids and peptides and the lower viability of L. bulgaricus can explain the observed lower values of 
VPP and IPP.  
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4. Conclusions 
From the results presented in this work, probiotic L. casei PRA205 was able to remain 
viable in cow milk yogurt after 28 d of storage at 4 °C with improved proteolysis, enhanced 
antioxidant properties, and increased ACEi activity compared to probiotic L. rhamnosus PRA331. 
The results of this study indicated that addition of probiotic L. casei PRA205 into cow milk yogurt 
manufacturing is an effective and scalable strategy to develop a bi-functional yogurt, which delivers 
viable probiotic cells at concentrations higher than the probiotic threshold and displays health status 
through increased antihypertensive and radical-scavenging capabilities. Furthermore, our work 
highlighted how combination of starter and probiotic cultures in dairy food fermentation resulted in 
complex interactions, which are beyond the additive properties of single mono-cultures. Microbial 
dynamics and competition for nutrients affect bacteria survivability, and shape metabolic bio-
functionalities, such as the release of antihypertensive and antioxidant peptides. Further studies are 
required to understand routes of formation and degradation of bioactive peptides in yogurt 
fermentation carried out by multiple microbial cultures. 
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Figure captions 
Fig. 1. Experimental strategy for the preparation and characterization of bi-functional 
yogurts. Panel A represents the rationale underlined the development of bi-functional yogurt, which 
is enriched in VPP and IPP (stars) and, at the same time, is carrier for potential probiotic cells 
(circles) capable to survive under GI stress. Panel B details the experimental steps performed for 
preparing and characterizing bi-functional yogurts. Yogurt starter cultures S. thermophilus strain 99 
and L. bulgaricus strain 1932 are generally represented as triangles, while L. casei PRA205 and L. 
rhamnosus PRA331 as circle and square, respectively. Abbreviation: NC, negative control. 
Fig. 2. Changes in bacterial viable counts during set-yogurt fermentation and cold 
storage. Panels A and B represent S. thermophilus (triangles) and L. bulgaricus (diamonds) viable 
populations, expressed as CFU/g, in yogurts 1 (black line), 2 (gray line) and 3 (dotted black line) 
after 8 h of fermentation and during cold storage, respectively. Panel C represents L. casei PRA205 
(circles) and L. rhamnosus PRA331 (squares) viable populations, expressed as CFU/g, in yogurts 2 
(gray line) and 3 (dotted black line) after 8 h of fermentation and during cold storage. # means P < 
0.05 respect to the previous time in each set-type yogurt; * means P < 0.05 respect to set-type 
yogurt 1 (control yogurt without probiotics). 
Fig. 3. Proteolytic activity of TCA-soluble peptide fractions extracted from yogurts 
after 8 h of fermentation and during 28-day long cold storage. Proteolytic activity values over 
time are mean (n ≥ 2) ± standard deviation (SD) and expressed as mmol/L leucine equivalents. 
Yogurts 1 (only yogurt starters), 2 (yogurt starters and probiotic PRA205) and 3 (yogurt starters and 
probiotic PRA331) are colored in black, white and gray, respectively. Bars with different letters are 
different from one another (P < 0.05) based on two-way ANOVA analysis of variance and 
subsequent Tukey’s post hoc test; upper case letters, yogurt 1 (control without probiotics); lower 
case letters, yogurts 2 and 3 with probiotics. ** means P < 0.01, *** means P < 0.005 while **** P 
< 0.0001. # means P < 0.05 respect to the previous time in each set-type yogurt 
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Fig. 4. Antioxidant activity of TCA-soluble peptide fractions extracted from yogurts. 
Radical scavenging activity values over time are mean (n ≥ 2) ± standard deviation (SD) and 
expressed as μmol/L Trolox equivalents. Yogurts 1 (only yogurt starters), 2 (yogurt starter and 
probiotic PRA205) and 3 (yogurt starter and probiotic PRA205) are colored in black, white and 
gray, respectively. Bars with different letters are different from one another (P < 0.05) based on 
two-way ANOVA analysis of variance and subsequent Tukey’s post hoc test; upper case letters, 
yogurt 1 (control without probiotics); lower case letters, yogurts 2 and 3 with probiotics. * means P 
≤ 0.05, while **** P < 0.0001. # means P < 0.05 respect to the previous time in each set-type 
yogurt. 
Fig. 5. Angiotensin-converting enzyme inhibitory activity (ACEi) of TCA-soluble 
peptide fractions extracted from yogurts. The extent of in vitro ACE inhibitory activity was 
calculated over time as a percentage mean (n ≥ 2). Yogurts 1 (only yogurt starters), 2 (yogurt 
starters and probiotic PRA205) and 3 (yogurt starters and probiotic PRA331) are colored in black, 
white and gray, respectively. Bars with different letters are different from one another (P < 0.05) 
based on two-way ANOVA analysis of variance and subsequent Tukey’s post hoc test; upper case 
letters, yogurt 1 (control without probiotics); lower case letters, yogurts 2 and 3 with probiotics. *** 
means P ≤ 0.005, while **** P < 0.0001. # means P < 0.05 respect to the previous time in each set-
type yogurt. 
Fig.6. Concentrations of lactotripeptides VPP (panel A) and IPP (panel B) in 
refrigerated yogurts. TCA soluble fractions were extracted from starter yogurt 1 (black bars) and 
probiotic yogurts 2 (white bars) and 3 (gray bars) after 3, 14 and 28 days of cold storage. Values 
(μg/L) are means of at least two independent replicates ± standard deviation (SD). Bars with 
different letters are different from one another (P < 0.05) based on two-way ANOVA analysis of 
variance and subsequent Tukey’s post hoc test; upper case letters, yogurt 1 (control without 
probiotics); lower case letters, probiotic yogurts 2 and 3. *** means P < 0.005, while **** P < 
0.0001. 
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Supporting Information 
Table S1. Correlation curves of optical density (OD) versus cell count (CFU/mL) and 
conversion factors for each bacterial strain. 
Fig. S1. Proteolytic activities of mono-cultures during milk fermentation. Proteolytic 
activity (expressed as mmol/L of leucine equivalents) is measured during milk fermentation with S. 
thermophilus 99 (black triangle), L. bulgaricus 1932 (empty triangle), L. casei PRA205 (black 
circles) and L. rhamnosus PRA331 (black squares). 
Fig. S2. Yogurt acidification kinetics. Triangles represent yogurt 1 (starter cultures S. 
thermophilus 99 and L. bulgaricus 1932), whereas circles and squares yogurt 2 (starter cultures S. 
thermophilus 99 and L. bulgaricus 1932 and probiotic strain L. casei PRA205) and yogurts 3 
(starter cultures S. thermophilus 99 and L. bulgaricus 1932 and probiotic strain L. rhamnosus 
PRA331), respectively. Data are represented by the mean (n = 3); error bars (when visible) show 
standard deviation. * means P < 0.05 respect to the yogurt 1 used as control. Non-inoculated yogurt 
maintained pH of 6.53 ± 0.2 for all the fermentation time and was omitted from the figure. 
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Table S1. 
Strain Correlation curve Conversion factor  
OD600=1 (CFU/mL) 
St. thermophilus 99 y=6*108x + 5∙106 6.05∙108 
L. delbrueckii subsp. bulgaricus 
1932 
y=3*107x-6∙106 2.4∙107 
L. casei PRA205 y=8*107x-6∙106 7.4∙107 
L. rhamnosus PRA331 y=5*107x - 2∙106 4.8∙107 
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